A significant advance in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This vital malignant suppressor protein is frequently lost in many types of tumors, causing https://bookmarklethq.com/story21917445/mini-antibodies-revive-the-p53-protein-a-promising-hope-for-tumor-treatment